Clinical Trial Update: Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two etanercept regimens for rheumatoid arthritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• REUMATOCEPT (etanercept)

Snippet

Sponsor: EMS | Conditions: Rheumatoid Arthritis | Phase 3 | Status: WITHDRAWN